Clinical Trials Browser

Phase 1 × INDUSTRY × Neuroendocrine Prostate Cancer × Clear all

NCT04702737 2025-09-12

DeLLpro-300

Phase 1 Completed

41 enrolled 19 charts

EndocrineGenitourinary

Neuroendocrine Prostate Cancer